RECRUITINGOBSERVATIONAL
Pre-operative Therapy in Breast Cancer
The Effect of Pre-operative Therapy on Response and Survival in Breast Cancer
About This Trial
This is a prospective and retrospective study to evaluate the effect of pre-operative therapy on response and survival, and compare the difference in response and survival by pre-operative regimen or by patient's clinicopathological characteristic in early or advanced breast cancer.
Who May Be Eligible (Plain English)
Who May Qualify:
- Female, Aged ≥18 years
- diagnosed by tissue sample (biopsy-confirmed) primary breast cancer
- Plan to receive pre-operative therapy
- your organs (liver, kidneys, etc.) are working well enough based on blood tests
Who Should NOT Join This Trial:
- History of neurological or psychological disease, including epilepsy or dementia
- Not suitable to participate in this study judged by investigators
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Female, Aged ≥18 years
* Histologically confirmed primary breast cancer
* Plan to receive pre-operative therapy
* Adequate organ function
Exclusion Criteria:
* History of neurological or psychological disease, including epilepsy or dementia
* Not suitable to participate in this study judged by investigators
Treatments Being Tested
DRUG
pre-operative therapy
pre-operative therapy includes pre-operative chemotherapy, radiation, endocrine therapy, target therapy and other anti-tumor therapy
Locations (1)
Renji Hospital, School of Medicine, Shanghai Jiaotong University
Shanghai, China